Simons S S, Chakraborti P K, Cavanaugh A H
Steroid Hormones Section, National Institute of Diabetes and Digestive and Kidney Diseases, Laboratory of Analytical Chemistry, National Institutes of Health, Bethesda, Maryland 20892.
J Biol Chem. 1990 Feb 5;265(4):1938-45.
Low concentrations of arsenite, but not arsenate, and Cd2+ blocked steroid binding to the glucocorticoid receptors of HTC cells. Inhibition by arsenite was faster and occurred at lower concentrations than for Cd2+. Half-maximal inhibition of [3H]dexamethasone binding was seen after a 30-min preincubation with approximately 7 microM arsenite. The effect of arsenite and of Cd2+ appears to be mediated by a reaction with vicinal dithiols of the receptor as shown by (a) the reversal of arsenite inhibition by much lower concentrations of dithiothreitol (approximately 0.1 mM) than of beta-mercaptoethanol (approximately 10 mM); (b) the ability of both arsenite and Cd2+ to block [3H]dexamethasone 21-mesylate labeling of receptors but not of other thiol-containing proteins; and (c) the known selectivity of arsenite and of Cd2+ for reactions with vicinal dithiols. Arsenite forms a tight complex with these vicinal dithiols since the removal of loosely associated arsenite by gel exclusion chromatography did not reverse the inhibition of steroid binding. The effect of other ions on steroid binding was also examined. Half-maximal inhibition of binding occurred with approximately 5 microM selenite, whereas up to 300 microM Zn2+ was without effect. Much higher concentrations of arsenite were required for effects on unactivated and activated complexes. Arsenite slowly induced a loss of unactivated complexes but rapidly inhibited a portion of the DNA binding of activated complexes. Any effect on activation occurred at arsenite concentrations equal to or higher than those that inhibited DNA binding. In contrast, Cd2+ concentrations similar to those that block steroid binding caused a biphasic loss of unactivated complexes and a marginal loss of activated complexes. This is the first report of effects of arsenite on glucocorticoid receptors. These results confirm directly our earlier hypothesis that steroid binding to rat glucocorticoid receptors involves a vicinal dithiol (Miller, N. R., and Simons, S. S., Jr. (1988) J. Biol. Chem. 263, 15217-15225) and show that arsenite is a potent new reagent for probing receptor structure and function.
低浓度的亚砷酸盐(而非砷酸盐)和Cd2+会阻止类固醇与HTC细胞的糖皮质激素受体结合。亚砷酸盐的抑制作用比Cd2+更快,且在更低浓度下就会发生。与大约7 microM亚砷酸盐预孵育30分钟后,[3H]地塞米松结合的半数抑制率出现。亚砷酸盐和Cd2+的作用似乎是通过与受体的邻二硫醇反应介导的,这表现为:(a) 比β-巯基乙醇(约10 mM)浓度低得多的二硫苏糖醇(约0.1 mM)就能逆转亚砷酸盐的抑制作用;(b) 亚砷酸盐和Cd2+都能阻止受体的[3H]地塞米松21-甲磺酸盐标记,但不能阻止其他含硫醇蛋白质的标记;(c) 已知亚砷酸盐和Cd2+与邻二硫醇反应具有选择性。亚砷酸盐与这些邻二硫醇形成紧密复合物,因为通过凝胶排阻色谱法去除松散结合的亚砷酸盐并不能逆转对类固醇结合的抑制作用。还研究了其他离子对类固醇结合的影响。结合的半数抑制率在约5 microM亚硒酸盐时出现,而高达300 microM的Zn2+则无作用。对未活化和活化复合物产生影响需要更高浓度的亚砷酸盐。亚砷酸盐会缓慢导致未活化复合物的丧失,但会迅速抑制活化复合物的一部分DNA结合。对活化的任何影响都发生在等于或高于抑制DNA结合的亚砷酸盐浓度下。相比之下,与阻止类固醇结合的浓度相似的Cd2+会导致未活化复合物的双相丧失和活化复合物的少量丧失。这是关于亚砷酸盐对糖皮质激素受体作用的首次报道。这些结果直接证实了我们早期的假设,即类固醇与大鼠糖皮质激素受体的结合涉及邻二硫醇(米勒,N. R.,和西蒙斯,S. S.,Jr.(1988年)《生物化学杂志》263,15217 - 15225),并表明亚砷酸盐是一种用于探究受体结构和功能的有力新试剂。